Non Serious Adverse Drug Reactions Report

Start Date:2016-05-12 End Date:2016-05-13
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0059Subject Initials :J-LDOB :12/23/1984Sex:FemaleRace:AsianHeight:155cmWeight:50.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/31/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



12-MAY-16
NA/EMR700623-541/C02-0059
Page 1 of10
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-12 End Date:2016-05-13
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0062Subject Initials :FQRDOB :07/25/1983Sex:FemaleRace:AsianHeight:162cmWeight:46.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/30/201506/03/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Hysteroscopic tubal inspectionUk-May-2014Not on treatment/medication



12-MAY-16
NA/EMR700623-541/C02-0062
Page 2 of10
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-12 End Date:2016-05-13
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0071Subject Initials :LLXDOB :07/13/1987Sex:FemaleRace:AsianHeight:157cmWeight:41.5kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/15/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/31/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparoscopic pelvic sub sticky, sticky points left fallopian tube surgery.Uk-Unk-2014Not on treatment/medication



12-MAY-16
NA/EMR700623-541/C02-0071
Page 3 of10
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-12 End Date:2016-05-13
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0115Subject Initials :KJTDOB :07/02/1988Sex:FemaleRace:AsianHeight:163cmWeight:52.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/21/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/05/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG examination: bilateral tubal occlusionUk-Unk-2012Not on treatment/medication
Laparoscopy surgery: pelvic sticky points, bilateral tubal ostomy + right side mesosalpinx cyst removal.Uk-May-2015Not on treatment/medication



12-MAY-16
NA/EMR700623-541/C02-0115
Page 4 of10
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-12 End Date:2016-05-13
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0118Subject Initials :MLFDOB :08/03/1984Sex:FemaleRace:AsianHeight:160cmWeight:55.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/21/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/07/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal obstruction Uk-Unk-2007Not on treatment/medication
Laparoscopic pelvic sticky points, bilateral ovarian drillingUk-Unk-2007Not on treatment/medication
Cervical biopsy showing inflammationUk-Unk-2015Not on treatment/medication



12-MAY-16
NA/EMR700623-541/C02-0118
Page 5 of10
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-12 End Date:2016-05-13
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0126Subject Initials :RCMDOB :01/09/1989Sex:FemaleRace:AsianHeight:165cmWeight:60.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/21/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/07/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: the right fallopian tube obstruction, poor uterine shape Uk-Unk-2013Not on treatment/medication
Hysteroscopy: uterine spindle-shaped, single horn.Uk-Unk-2014Not on treatment/medication



12-MAY-16
NA/EMR700623-541/C02-0126
Page 6 of10
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-12 End Date:2016-05-13
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0134Subject Initials :QYLDOB :06/17/1986Sex:FemaleRace:AsianHeight:155cmWeight:47.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/22/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/06/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparotomy: pelvic abscess incision and drainage, the right accessories cystectomyUk-Unk-2009Not on treatment/medication
Hysteroscopy normal uterine shapeUk-Unk-2013Not on treatment/medication
Hysteroscopic curettageUk-Unk-2015Not on treatment/medication



12-MAY-16
NA/EMR700623-541/C02-0134
Page 7 of10